
Conference Coverage
Latest Content

Navigating Costs and Logistics of Cellular Therapies, ADCs, and Novel Diagnostics in Cancer Care

Team-Based Precision Oncology: Advancing Value and Access in Cancer Care

Culturally Competent Menopause Care: Lisa Taylor-Swanson, PhD

Raludotatug Deruxtecan Demonstrates Promising Efficacy, Safety in Platinum-Resistant Ovarian Cancer

Rare Case of Soft Tissue Sarcoma Spreading to the Heart Highlights Diagnostic, Therapeutic Challenges

Shorts










Podcasts
Center on Health Equity & Access
Continuing Medical Education
All News

As open enrollment begins November 1, 2025, millions are signing up under enhanced subsidies that are set to expire at the end of this year.

Researchers have developed a machine learning model that reliably predicts pulmonary hypertension (PH) risk in patients with chronic kidney disease (CKD).

Despite social media frenzy, there is limited evidence around testosterone’s impact on muscle, mood, and other menopausal symptoms.

Experts discuss personalized myasthenia gravis treatment, emphasizing patient education and engagement for optimal care and advocacy in managing this variable disease.

Individuals with both low incomes and health problems were more likely to gain employment when covered by Medicaid.

Bariatric surgery halves mortality and reduces liver, heart, and kidney complications in steatotic liver disease vs nonsurgical care.

Marcus Flores, PharmD, BCPS, BCOP, discusses the vital role of pharmacists in multidisciplinary cancer care, exploring collaboration, patient-centered strategies, and AI.

Nerandomilast slowed disease progression at 2 doses compared with placebo among US participants in the trial.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

The study underscores the importance of repeat testing in cases where myelin oligodendrocyte glycoprotein immunoglobulin G tests are borderline.
































































